2Behrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction [ J ]. N Engl J Med, 2001,344 ( 23 ) : 1750-1757.
3Hunter J J, Chien KR. Signaling pathways for cardiac hypertrophy and failure [ J ]. N Engl J Med, 1999,341 ( 17 ) : 1276-1283.
4Yamazaki T, Komuro I, Yazaki Y. Signaling pathways for cardiac hypertrophy [ J ]. Cell Signal, 1998,10 (10) :693-698.
5Ishigai Y, Mori T, Ikeda T, et al. Role of bradykinin NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes [ J ]. Am J Physiol, 1997,273 : H2659-H2663.
6Calderone A,Thaik CM, Takahashi N, et al. Nitric oxide, atrial natriuretic peptide,and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts [ J ]. J Clin Invest, 1998,101:812-818.
7Kanai A J, Mesaros S, Finkel MS,et al. Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes [ J ]. Am J Physiol, 1997,273 :C1371- C1377.
9Johnson JA. An epsilon PKC-selective inhibitor attenuates back phosphorylation of a low molecular weight protein in cardiac myocytes [ J ]. Cell Signal,2003,15 : 123-130.
10Aoki H, Richmond M, Lzumo S, et al. Specific role of the extraceUular signalregulated kinase pathway in angiotensin Ⅱ induced cardiac hypertrophy in vitro [ J ]. Biochem J,2000,347 (1) :275 -284.
